A Comparative Study of Soft Tissue Sarcomas of the Extremities: Brachytherapy versus Radiotherapy
,
Abstract
Background: Soft tissue sarcoma (STS) is a wide group of solid tumors with specific features originating from mesenchymal tissue. Radiotherapy (RT) and chemotherapy have been widely applied in the treatment of these tumors to enhance surgical outcomes. This study was performed aiming to compare the results of postoperative brachytherapy (BRT) versus RT in patients who underwent surgical resection of extremity STSs.
Methods: In a prospective study from 2011 to 2015, 166 patients with extremity STS who underwent surgical resection were included. All visible tumors, scars, and drain sites, if present during the surgery, were resected. A number of 79 patients received adjuvant RT, and 87 patients underwent BRT after surgical resection.
Results: In patients who were treated through RT, the two-year local control was 90% in comparison with 87% for those treated through BRT (P > 0.050). The total radiation dose was 3869 ± 370 and 3048 ± 465 in the patients who underwent RT and in the BRT group (P < 0.001), respectively. The number of radiation sessions in the RT group and BRT group was respectively 27.3 ± 4.5 and 5.8 ± 2.0 (P = 0.001).
Conclusion: Not only BRT can lead to similar local control and survival in comparison with the conventional adjuvant RT, but it can also decrease the total dose and number of radiation sessions in patients with STS of the extremity, which is a high grade, in individuals who underwent surgical resection.
2. Koshy M, Rich SE, Mohiuddin MM. Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities: A SEER analysis. Int J Radiat Oncol Biol Phys. 2010;77(1):203-9. doi: 10.1016/j.ijrobp.2009.04.051. [PubMed: 19679403]. [PubMed Central: PMC3812813].
3. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, et al. The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305-15. doi: 10.1097/00000658-198209000-00009. [PubMed: 7114936]. [PubMed Central: PMC1352604].
4. Liu YZ, Hou FQ, Ding P, Ren YY, Li SH, Wang GQ. Pegylated interferon alpha enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients. Virol J. 2012;9:274. doi: 10.1186/1743-422X-9-274. [PubMed: 23158844]. [PubMed Central: PMC3518195].
5. Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014;32(29): 3236-41. doi: 10.1200/JCO.2013.53.9452. [PubMed: 25185087]. [PubMed Central: PMC4178522].
6. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14(3):859-68. doi: 10.1200/JCO.1996.14.3.859. [PubMed: 8622034].
7. Hilaris BS, Bodner WR, Mastoras CA. Role of brachytherapy in adult soft tissue sarcomas. Semin Surg Oncol. 1997;13(3): 196-203. doi: 10.1002/(sici)1098-2388(199705/06)13:3<196::aid-ssu7>3.0.co;2-2. [PubMed: 9143058].
8. Cox DR. Regression models and life-tables. J R Stat Soc Series B
Stat Methodol. 1972;34(2):187-202. doi: 10.1111/j.2517-
6161.1972.tb00899.x
9. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197-203. doi: 10.1200/JCO.1998.16.1.197. [PubMed: 9440743].
10. Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet. 2015;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. [PubMed: 25771249].
11. Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021-30. doi: 10.1016/j.ijrobp.2008.02.040. [PubMed: 18556141]. [PubMed Central: PMC3782859].
12. Beane JD, Yang JC, White D, Steinberg SM, Rosenberg SA, Rudloff U. Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Ann Surg Oncol. 2014;21(8):2484-9. doi: 10.1245/s10434-014-3732-4. [PubMed: 24756814]. [PubMed Central: PMC6293463].
13. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol. 2006;176(4 Pt 1):1415-9. doi: 10.1016/j.juro.2006.06.002. [PubMed: 16952647].
14. Zelefsky MJ, Yamada Y, Cohen GN, Shippy A, Chan H, Fridman D, et al. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007;67(1):65-70. 10.1016/j.ijrobp.2006.08.030. [PubMed: 17189063].
| Files | ||
| Issue | Vol 7, No 4 (2021) | |
| Section | Research Articles | |
| DOI | https://doi.org/10.18502/jost.v7i4.8859 | |
| Keywords | ||
| Sarcoma; Brachytherapy; Radiotherapy | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
